| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/25/2012 | CN101732724B 一种携载抗肿瘤药物的复合胶束及其制备方法 One kind of carrying antineoplastic complex micelles and its preparation method |
| 04/25/2012 | CN101732247B 一种含有依达拉奉的注射液 Containing edaravone injection |
| 04/25/2012 | CN101708204B 一种治疗心脑血管病的药物组合物 A method of treating cardiovascular diseases pharmaceutical composition |
| 04/25/2012 | CN101703499B 两种化学抗肿瘤药物 Two chemical anticancer drugs |
| 04/25/2012 | CN101684163B 一种天麻多糖硫酸化衍生物及其制备方法和抗肿瘤用途 One kind of Gastrodia sulfated polysaccharide derivatives, preparation method and use of anti-tumor |
| 04/25/2012 | CN101675930B 用于治疗增生性疾病的药物组合物 For the treatment of proliferative diseases, pharmaceutical compositions |
| 04/25/2012 | CN101664390B 一种前列地尔脂微球的制备方法 One kind of alprostadil lipid microsphere preparation |
| 04/25/2012 | CN101619055B 氯化染料木素及其生物转化制备和应用方法 Preparation and application methods chlorinated genistein and biotransformation |
| 04/25/2012 | CN101602754B 一种二氢黄酮类衍生物及其制备方法和用途 One kind of flavanone derivatives and their preparation and use |
| 04/25/2012 | CN101591315B Novel homoisoflavone compound and application thereof |
| 04/25/2012 | CN101579349B 一种中药制剂 A traditional Chinese medicine preparation |
| 04/25/2012 | CN101574445B 一种具有口腔保健功效的中药组合物 Chinese medicine composition with the efficacy of oral health |
| 04/25/2012 | CN101568539B 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物 For imidazolinone amino pyrimidine compounds for treating cancer |
| 04/25/2012 | CN101548946B 姜黄素纳米脂质注射液、其制备方法及用途 Curcumin Nanoliposomal injection, their preparation and use |
| 04/25/2012 | CN101544578B 苯乙酸衍生物其制备方法以及其在药物中的应用 Phenylacetic acid derivatives for their preparation and their use in medicine |
| 04/25/2012 | CN101536989B 盐酸二甲双胍胃内漂浮缓释片及其制备方法 Intragastric floating sustained-release tablets of metformin hydrochloride and its preparation method |
| 04/25/2012 | CN101511831B 作为a2a受体激动剂的腺苷衍生物 As the derivatives of adenosine a2a agonist |
| 04/25/2012 | CN101495452B Ep2激动剂 Ep2 agonists |
| 04/25/2012 | CN101472906B 作为用于治疗认知损伤的、具有结合的对血清素再吸收、5-ht3和5-ht1a活性的化合物的1-[2-(2,4-二甲基苯基硫烷基)-苯基]哌嗪 As for the treatment of cognitive impairment, with binding to serotonin reuptake, 1- [2- (2,4-Dimethyl-phenylsulfanyl) 5-ht3 and 5-ht1a active compounds - benzene yl] piperazine |
| 04/25/2012 | CN101456863B Novel LXR agonist as well as preparation method and application thereof |
| 04/25/2012 | CN101442996B 抗微生物剂以及抗微生物组合物 The antimicrobial agents and antimicrobial composition |
| 04/25/2012 | CN101437514B C-fms激酶抑制剂 C-fms kinase inhibitor |
| 04/25/2012 | CN101426774B Azolecarboxamide derivative |
| 04/25/2012 | CN101415703B 用作肾素抑制剂的取代的4-苯基哌啶 Used as the inhibitors of the renin-substituted 4-phenyl-piperidine |
| 04/25/2012 | CN101406463B 双唑泰阴道泡腾片及制备方法 Metronidazole vaginal effervescent tablets and preparation methods |
| 04/25/2012 | CN101404990B 含有味道被掩蔽的活性剂的固体剂型 The solid dosage form containing a taste masked active agent |
| 04/25/2012 | CN101397295B 作为组蛋白去乙酰化酶抑制剂的2-吲哚满酮衍生物、其制法和用途 As a histone deacetylase inhibitor 2-indolinone derivatives, their preparation and use |
| 04/25/2012 | CN101396115B 一种低聚木糖健胃润肠口服液及其制备方法 One kind of stomach and intestines XOS oral and preparation method |
| 04/25/2012 | CN101374835B 作为PTPase抑制剂的取代的咪唑衍生物、组合物和使用方法 PTPase inhibitors as substituted imidazole derivatives, compositions and methods of use |
| 04/25/2012 | CN101347620B 一种药物组合物及其在制备治疗青光眼的药物中的应用 A pharmaceutical composition for the treatment of glaucoma and pharmaceutical application in the preparation of |
| 04/25/2012 | CN101343303B 一种治疗艾滋病的药物化合物及其制备方法和应用 A method of treating AIDS drug compound and its preparation method and application |
| 04/25/2012 | CN101337000B 龙葵提取物、其制备方法及其药物用途 Solanum nigrum extract, their preparation and their pharmaceutical use |
| 04/25/2012 | CN101287460B Compositions for the prevention and treatment of kidney disease |
| 04/25/2012 | CN101284795B 一类非甾体雄激素受体调节剂及其医学用途 A class of non-steroidal androgen receptor modulators and their medical uses |
| 04/25/2012 | CN101252925B 以逆转录酶抑制剂和美度铵为基础的药物组合物 With reverse transcriptase inhibitors and beauty of the ammonium-based pharmaceutical composition |
| 04/25/2012 | CN101199615B 一种治疗口腔溃疡的外用内服口腔崩解片及其制备方法 A method of treating mouth ulcers topical oral orally disintegrating tablets and its preparation method |
| 04/25/2012 | CN101199560B Ginkgo leaf extract and preparing method thereof |
| 04/25/2012 | CN101181548B 一种含有天然抗菌剂的药用或保健组合物 Pharmaceutical or health care composition containing a natural antimicrobial agent |
| 04/25/2012 | CN101181277B 含核苷酸类似物的组合物及其合成方法 Compositions containing nucleotide analogs and synthetic methods |
| 04/25/2012 | CN101124220B 5-取代的喹啉和异喹啉衍生物、其制备方法及其作为抗炎药的用途 5-substituted quinoline and isoquinoline derivatives, their preparation and their use as anti-inflammatory agents |
| 04/25/2012 | CN101040933B 维生素e的复合胶囊 Complex vitamin e capsules |
| 04/25/2012 | CN101006077B Crystalline form of a biphenyl compound |
| 04/25/2012 | CA2755582A1 Compositions comprising a retinoid and an nfkb-inhibitor and their methods of use |
| 04/24/2012 | USRE43327 Hydrophobic polyamine analogs and methods for their use |
| 04/24/2012 | US8163960 Process for preparing and drying solid rasagiline base |
| 04/24/2012 | US8163958 Levodopa prodrugs, and compositions and uses thereof |
| 04/24/2012 | US8163957 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease |
| 04/24/2012 | US8163956 Inhibitors of GLYT1 transporters |
| 04/24/2012 | US8163953 Compounds for lysosomal modulation and methods of use |
| 04/24/2012 | US8163938 Aminocyclohexyl ether compounds and uses thereof |
| 04/24/2012 | US8163936 Treatment of CRTH2-mediated diseases and conditions |
| 04/24/2012 | US8163935 Fused heterocyclic compounds |
| 04/24/2012 | US8163932 Substituted indolealkanoic acids |
| 04/24/2012 | US8163931 Treatment of CRTH2-mediated diseases and conditions |
| 04/24/2012 | US8163929 Dihydropyridone amides as P2X7 modulators |
| 04/24/2012 | US8163927 Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors |
| 04/24/2012 | US8163921 Hepatitis C virus inhibitors |
| 04/24/2012 | US8163920 Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| 04/24/2012 | US8163919 Imidazopyridinyl benzamide mitotic kinesin inhibitors |
| 04/24/2012 | US8163909 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 04/24/2012 | US8163908 Sirtuin modulating compounds |
| 04/24/2012 | US8163904 Prepared by reacting free base with an acid in methanol under a nitrogen atmosphere; use in treating a disease which responds to an inhibition of protein kinase activity |
| 04/24/2012 | US8163902 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 04/24/2012 | US8163901 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 04/24/2012 | US8163806 Controlled release of biologically active compounds from multi-armed oligomers |
| 04/24/2012 | US8163805 Small molecule antagonists of Bcl-2 family proteins |
| 04/24/2012 | US8163803 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of disease |
| 04/24/2012 | US8163802 Electrostatically charged multi-acting nasal application, product, and method |
| 04/24/2012 | US8163801 Enzymatic production of peracids using perhydrolytic enzymes |
| 04/24/2012 | US8163800 PKC-activating compounds for the treatment of neurodegenerative diseases |
| 04/24/2012 | US8163799 Amido-amine polymer compositions |
| 04/24/2012 | US8163798 Administering methylphenidate at an ascending release rate over an extended time period; therapeutic affect over long time period; hyperactivity/attention deficit disorder |
| 04/24/2012 | US8163797 Method of treating with stable pravastatin formulation |
| 04/24/2012 | US8163796 Treatment of cancer by oxidation-reduction potentiation of cancerostatic dicarbonyls |
| 04/24/2012 | US8163795 Chroman derivatives, medicaments and use in therapy |
| 04/24/2012 | US8163794 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
| 04/24/2012 | US8163793 Proline derivatives |
| 04/24/2012 | US8163792 IAP BIR domain binding compounds |
| 04/24/2012 | US8163791 Imidazole derivatives that induce apoptosis and their therapeutic uses |
| 04/24/2012 | US8163790 Metronidazole cocrystals and imipramine cocrystals |
| 04/24/2012 | US8163789 Selective and dual-action p53/MDM2/MDM4 antagonists |
| 04/24/2012 | US8163788 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors |
| 04/24/2012 | US8163787 Triazolone derivatives |
| 04/24/2012 | US8163786 Preparation of a lead-free primary explosive |
| 04/24/2012 | US8163785 Pyrazolo[5,1b]oxazole derivatives as CRF-1 receptor antagonists |
| 04/24/2012 | US8163784 Biocidal compositions |
| 04/24/2012 | US8163783 Ribonucleotide reductase inhibitors and methods of use |
| 04/24/2012 | US8163782 1,2,4-oxadiazole benzoic acid compositions |
| 04/24/2012 | US8163781 Bi-aryl aminotetralines |
| 04/24/2012 | US8163780 Nicotine receptor agonists in stem cell and progenitor cell recruitment |
| 04/24/2012 | US8163779 Glucokinase activators |
| 04/24/2012 | US8163778 Pyridines as FBPase inhibitors for treatment of diabetes |
| 04/24/2012 | US8163777 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses |
| 04/24/2012 | US8163776 Immunomodulation by administering thione-forming dithiobis-heterocyclic compound, increased natural killer cell activity, expansion of NK cell population, decreased B cell population, decreased antibody production |
| 04/24/2012 | US8163775 Allosteric modulators of metabotropic glutamate receptors |
| 04/24/2012 | US8163774 Antidiabetic agents; 2-(amino-substituted piperidin-1-yl)benzimidazoles; N-(4-Chlorobenzyl)-2-(3-aminopiperidin-1-yl)-1-(4-fluorobenzyl)-1H-benzimidazole-6-carboxamide hydrochloride for example; use in combination with other antidiabetic, antilipemic agents |
| 04/24/2012 | US8163773 Organic compounds |
| 04/24/2012 | US8163772 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 04/24/2012 | US8163771 11 β-HSD1 modulators |
| 04/24/2012 | US8163770 Benzoxathiin derivative |